Assessment of prognosis and curative effect in patients with chronic severe hepatitis using the model for end-stage liver disease scores
Chi-hong Wu(Peking University), Haiying Lu(Shanghai University of Traditional Chinese Medicine), Xiaoyuan Xu(Columbia University), Geng-shan Tian(Peking University), Yan-yan Yu(Xuzhou Medical College)
Cited by 3
Related Papers
RAGE Regulates the Metabolic and Inflammatory Response to High-Fat Feeding in Mice
|Diabetes|2014|202
On‐treatment changes of liver stiffness at week 26 could predict 2‐year clinical outcomes in <scp>HBV</scp>‐related compensated cirrhosis
|Liver International|2017|41
Sesquiterpene lactones from Sonchus arvensis L. and their antibacterial activity against Streptococcus mutans ATCC 25175
|Fitoterapia|2009|33
Prevalence of antinuclear and anti-liver-kidney-microsome type-1 antibodies in patients with chronic hepatitis C in China.
|PubMed|2009|27
Clinical application of artificial liver and blood purification: expert consensus recommendations
|Hepatology International|2022|24